✦ LIBER ✦
Moderately high-dose carboplatin with paclitaxel and intraperitoneal cisplatin improves progression-free survival but has higher toxicity than standard intravenous cisplatin and paclitaxel for small volume ovarian cancer
✍ Scribed by Mario De Lena
- Book ID
- 114483811
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 186 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1363-4054
No coin nor oath required. For personal study only.